Clinical Trial Update: Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial investigating canakinumab in individuals with newly diagnosed type 1 diabetes; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Canakinumab (canakinumab)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Type 1 Diabetes, Preservation of Insulin Secretion | Phase 2 | Status: COMPLETED | Results posted: 2016-10-18